25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas
- PMID: 37951853
- DOI: 10.1007/s00277-023-05536-4
25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas
Abstract
The aim of the study was to explore the significance and prognostic value of 25-hydroxy vitamin D (25-(OH) D) deficiency in peripheral T-cell lymphomas (PTCLs). One hundred fifty-six patients of newly diagnosed PTCLs were enrolled in the study. Univariate and multivariate regression analyses were performed to determine independent risk factors for progression-free survival (PFS) and overall survival (OS). Receiver operating characteristic (ROC) curves were plotted, and corresponding areas under the curve (AUC) were calculated to estimate the accuracy of International Prognostic Index (IPI) plus 25-(OH) D deficiency and Prognostic Index for T-cell lymphoma (PIT) plus 25-(OH) D deficiency respectively in PTCL risk stratification. Our results showed that the 25-(OH) D deficiency was an independent inferior prognostic factor for both PFS (P = 0.0019) and OS (P = 0.005) for PTCLs, especially for AITL and PTCL-not otherwise specified (PTCL-NOS). Additionally, adding 25-(OH) D deficiency to PIT indeed has a superior prognostic significance than PIT alone for PFS (P = 0.043) and OS (P = 0.036). Multivariate COX regression analysis revealed that PIT 2‒4, albumin (ALB) ≤ 35 g/L, and 25-(OH) D deficiency were regarded as independent risk factors of PFS and OS. Our results showed that 25-(OH) D deficiency was associated with inferior survival outcome of PTCLs, especially for AITL and PTCL-NOS. PIT plus 25-(OH) D deficiency could better indicate the prognosis for PFS and OS of PTCLs than PIT.
Keywords: 25-(OH)D deficiency; Peripheral T-cell lymphomas; Prognosis; Survival.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms [J]. Blood 127(20):2375–2390. https://doi.org/10.1182/blood-2016-01-643569 - DOI - PubMed - PMC
-
- Fiore D, Cappelli LV, Broccoli A, Zinzani PL, Chan WC, Inghirami G (2020) Peripheral T cell lymphomas: from the bench to the clinic [J]. Nat Rev Cancer 20(6):323–342. https://doi.org/10.1038/s41568-020-0247-0 - DOI - PubMed
-
- Vose J, Armitage J, Weisenburger D, International T C L P (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes [J]. J Clin Oncol 26(25):4124–4130. https://doi.org/10.1200/JCO.2008.16.4558 - DOI - PubMed
-
- Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M et al (2012) Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification [J]. Am J Clin Pathol 138(3):429–434. https://doi.org/10.1309/AJCP7YLTQPUSDQ5C - DOI - PubMed
-
- Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY et al (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution [J]. Diagn Pathol 6:77. https://doi.org/10.1186/1746-1596-6-77 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
- 82200887/National Defense Science and Technology Innovation Fund of the Chinese Academy of Sciences
- 82370194/the National Natural Science Foundation of China
- BK20220716/Jiangsu Science and Technology Department
- grant number 2022M711404/China Postdoctoral Science Foundation
- PY2021028/Yong Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous